Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34526137

about

Viral hepatitis and hepatocellular carcinoma Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population.Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study Hepatitis B and hepatocellular carcinoma Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study.Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B.The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma.Telbivudine: a new option for the treatment of chronic hepatitis B.Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Real-time PCR assay using molecular beacon for quantitation of hepatitis B virus DNA.Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.Interferon-alpha therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece.Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load.Safety and long-term outcomes of anatomic left hepatic trisectionectomy for intermediate and advanced hepatocellular carcinoma.Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection

P2860

Q21245597-56EEE35B-E160-49E4-8367-D85D25EEEBFD Q26772209-B252E30E-5CDB-4307-A514-E56853E5A672 Q26799056-5CAE9A83-66BB-431D-A6B9-153844EBF84F Q26829868-EF76C845-353E-4966-B69D-9D5884E6B6FC Q28080587-46B93506-862A-4F9B-A1F0-8579622D9CC1 Q28392783-DF52B4E6-E45F-4004-9EF4-8645291FE93E Q28394414-9D41FDE0-0BB0-42DE-8460-66F0E8D82F00 Q33313034-B406F420-D035-407A-923B-794620B5C885 Q34458029-02054EDF-AD06-4936-8E61-2394790ABED7 Q34618351-C29CF05C-05BB-4E64-ADD8-2E0D44D094D9 Q35596851-1A8A8D26-3934-43A1-A428-74ED50549F0C Q35950941-21A97EB8-2842-49C2-BC33-6E690C9A5531 Q36120804-8EC9E4E4-773C-4C8D-9C67-76BCEF71DB6D Q36309223-7527FC58-DE52-4254-BFFC-178A39D5A03F Q36419017-4E901D42-5C56-4316-8DD2-029015F606A3 Q36810314-62F0E2BA-5097-4C6E-9337-93C8A86200B0 Q37263149-CFCD7085-F465-49C3-9A72-D6B9D78A615E Q37536785-2D6FD3CC-00E2-44BD-B474-E2E9A54A5644 Q37972806-E3023701-43D2-47FB-921A-EBC8E1A036CE Q39485250-AF6F14FB-BA4A-4415-87A7-B1C456292347 Q40140066-20C007BD-5304-4200-82A9-B5416ACFC038 Q40301022-17AAF5AF-D114-4628-8C5C-0D7BB3E22326 Q42209550-B35AD1B2-8942-4DBB-BA81-E0230A6311DB Q42251541-8420E7CA-3D71-4E3C-9E57-96FEA600B039 Q42967810-F8E34EB6-F87C-4FC4-8DAA-00D721A3C203 Q44109058-D86CD0DB-8EDE-407C-B99E-A206D59BC029 Q44895107-0494EE5A-319F-4B63-BB8B-E68E0916BB3E Q44902055-0265260D-19EB-4FE9-B9AE-ECECFFEE83B8 Q45360818-FC3DF71C-B3F9-42A7-8638-85E8872E5360 Q45397838-5757557B-49BB-4549-92AA-26ED9C67DA3F Q46408573-0BF12856-0698-4299-BCC8-5FD0D7C6277E Q53622404-A91D9C6D-F0C7-4AEC-8D02-15AA83E4DDC7 Q54711641-0F79B93D-79C4-47F0-B048-ED49AB322C1C Q59137661-476FB663-A483-4DA3-9051-F5626CFAAA2B

P2860

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34526137

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@ast

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@en

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@nl

type

label

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@ast

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@en

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@nl

prefLabel

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@ast

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@en

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@nl

P1433

Q34526137-EDF23689-6B67-4CCF-8D7B-314D40CB97BA

P1476

Q34526137-C1342AF9-CA50-4525-84D4-D9BEE205F1A9

P2093

Q34526137-0E543A12-8671-4448-8894-587A34FCB1B5

Q34526137-1EB82867-0654-4766-9E56-0DF8FE6639E0

Q34526137-29685AEF-8580-44AE-BE6C-BC2818A70018

Q34526137-51B7D8B3-866D-4725-8A7A-5E4CD26B8784

Q34526137-660EA0AA-C740-414D-9A22-059A794C12ED

Q34526137-75F520B3-3E33-467E-AD5C-2E39312493BD

Q34526137-78B8CDD7-6C29-46FC-9877-ED4C853BF93E

Q34526137-8CCD5706-2398-4C01-B810-93D5257BED06

Q34526137-ADA65C22-A42C-4A2F-954D-11E602CA1191

Q34526137-E49CEBC9-32B7-4488-99F0-A7E82D8E9890

P2860

Q34526137-03F0DA96-EFC3-4BF7-99A2-FB2FCF32E23B

Q34526137-066C274E-7993-4852-AD22-CD4C4D44433A

Q34526137-19A19C6A-C041-4AF3-B39F-22D3D0AF67BC

Q34526137-1E6E26FE-1718-4739-9ED3-0C940A394AC5

Q34526137-27C070E3-34C4-469B-B53C-F7953D0592F2

Q34526137-30880F1A-4D92-4D95-8273-F3A74BE45E46

Q34526137-3BBD082D-1F58-49E9-B58C-D88CE6D21488

Q34526137-50F04DD5-4529-4A16-B345-A4528715F847

Q34526137-84B3CDBA-76D2-4EF5-9ED0-CEF26ED035C9

Q34526137-8A3DFA23-63B8-4992-AA8F-E2A4889A6112

P304

Q34526137-D55CD199-D3B1-49D9-841F-99E1AE594381

P31

Q34526137-258B43B6-B5D9-48CC-88FE-15CFFF3A2A9E

P356

Q34526137-C28AC512-8515-468B-98D4-DF5D7456CCDB

P407

Q34526137-B18F3F1A-1DD0-431B-B9D3-AE2ABDD40191

P433

Q34526137-A2DE33F6-E87F-414F-99B5-B540D703B995

P478

Q34526137-B31C45E7-36AE-4C81-8C65-A2A23221CA60

P577

Q34526137-D4049DDB-B8A4-418D-B162-6FB4FA89349A

P5875

Q34526137-68D4003A-53D2-4980-8F32-99A17FF4ED07

P698

Q34526137-AB87D30A-F0E6-464B-984E-C3B46582A130

P921

Q34526137-8921E2F4-3670-41FB-9038-0BE363DC09BD

P356

P1433

P1476

Viral load is a significant pr ...... ated hepatocellular carcinoma.

@en

P2093

Katsumi Eguchi

http://www.w3.org/2001/XMLSchema#string

Kazuaki Ohkubo

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Nakao

http://www.w3.org/2001/XMLSchema#string

Keisuke Hamasaki

http://www.w3.org/2001/XMLSchema#string

Keisuke Nakata

http://www.w3.org/2001/XMLSchema#string

Shinnichirou Higashi

http://www.w3.org/2001/XMLSchema#string

Tatsuki Ichikawa

http://www.w3.org/2001/XMLSchema#string

Yoshio Takeda

http://www.w3.org/2001/XMLSchema#string

Yuji Kajiya

http://www.w3.org/2001/XMLSchema#string

Yuji Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleoside analogues in the treatment of chronic hepatitis B.

Clinical potential of emerging new agents in hepatitis B.

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.

A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus.

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.

HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.

P304

2663-2668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10557

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11214450

http://www.w3.org/2001/XMLSchema#string

P698

12173334

http://www.w3.org/2001/XMLSchema#string

P921